Esophageal Cancer Clinical Trial
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus)
Summary
A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).
Full Description
Patients will be enrolled in this study at the participating centers when evaluated in gastro-intestinal (GI) clinics and endoscopy suites. Initial evaluation of patients will include collection of data on demographics, assessment of risk factors such as smoking, metabolic syndrome, family history and detailed medication history, and past surgical history. All patients will be complete questionnaires regarding Gastroesophageal Reflux Disease (GERD) symptoms, GERD related quality of life (QOL) and overall health related QOL. Details of all previous endoscopic and surgical evaluation along with histopathology data will be documented. Patients undergoing endoscopic evaluation at the participating centers will have their endoscopic and histopathology results documented. This will include data collection regarding use of advanced imaging techniques, details regarding tissue acquisition, EET and adverse events. Patients undergoing esophagectomy will have surgical details documented along with complications related to surgery. Similarly, details regarding chemoradiation treatments will be documented .
Eligibility Criteria
Inclusion Criteria:
Patients with Barrett's related neoplasia and dysplasia. Patients with esophageal cancer
Exclusion Criteria:
Patients with squamous cell carcinoma
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 4 Locations for this study
Los Angeles California, 90095, United States More Info
Principal Investigator
Tampa Florida, 33612, United States More Info
Principal Investigator
Sub-Investigator
Chicago Illinois, 60611, United States More Info
Principal Investigator
How clear is this clinincal trial information?